Biomimetic Magnetic Nanocarriers Drive Choline Kinase Alpha Inhibitor inside Cancer Cells for Combined Chemo-Hyperthermia Therapy

• Main Authors: Ylenia Jabalera (Author), Alberto Sola-Leyva (Author), Ana Peigneux (Author), Federica Vurro (Author), Guillermo R. Iglesias (Author), Jesus Vilchez-Garcia (Author), Inmaculada Pérez-Prieto (Author), Francisco J. Aguilar-Troyano (Author), Luisa C. López-Cara (Author), María P. Carrasco-Jiménez (Author), Concepcion Jimenez-Lopez (Author)
• Format: Book
• Published: MDPI AG, 2019-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Choline kinase α1 (ChoKα1) has become an excellent antitumor target. Among all the inhibitors synthetized, the new compound Ff35 shows an excellent capacity to inhibit ChoKα1 activity. However, soluble Ff35 is also capable of inhibiting choline uptake, making the inhibitor not selective for ChoKα1....